Targeted drug delivery using nanobodies to deliver effective molecules to breast cancer cells: the most attractive application of nanobodies.

Abdolvahab, Mohadeseh Haji; Karimi, Pegah; Mohajeri, Nasrin; Abedini, Mohammad; Zare, Hamed

Abdolvahab, Mohadeseh Haji; Karimi, Pegah; Mohajeri, Nasrin; Abedini, Mohammad; Zare, Hamed.

Afiliación

Abdolvahab MH; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.
Karimi P; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.
Mohajeri N; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.
Abedini M; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.
Zare H; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran. hamed.zare1363@gmail.com.

Cancer Cell Int ; 24(1): 67, 2024 Feb 10.

Article en En | MEDLINE | ID: mdl-38341580

Palabras clave

Breast cancer; Drug delivery; Nanobody; VHH

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancer Cell Int Año: 2024 Tipo del documento: Article País de afiliación: Irán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google